PROYECTOS I+D
Project ECO2016-78685-R MEPRIC
LA MEDICINA PERSONALIZADA Y LOS CONTRATOS DE RIESGO COMPARTIDO COMO NUEVOS PARADIGMAS DE LA GESTIÓN SANITARIA: MODELOS ECONÓMICOS TEÓRICOS Y APLICACIONES
date_range
Duration: from 30 December 2016 to 29 December 2019
(36 months)
euro
13,310.00 EUR
Of National scope.
Researchers
Publications related to the project
Show by yearReview
Article
-
Pre-approval incentives to promote adoption of personalized medicine: A theoretical approach
2019
Health Economics Review
-
Personalized medicine and pay-for-performance: should pharmaceutical firms be fully penalized when treatment fails?
2018
PharmacoEconomics
-
EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?
2017
European Journal of Health Economics
-
Endogenous versus exogenous generic reference pricing for pharmaceuticals
2017
International Journal of Health Economics and Management